Skip to main content
Livermore
Livermore
ZHEN

First Manhattan Co

SEC CIK
0000728083
Latest filing
Aug 14, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
30,035
Value
$1.02M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by First Manhattan Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202630,035$1.02M<0.1%−13,640−31.2%ReducedHolders
Q1 202643,675$1.32M<0.1%+2,000+4.8%AddedHolders
Q4 202541,675$1.30M<0.1%+20,000+92.3%AddedHolders
Q3 202521,675$437.8K<0.1%00.0%UnchangedHolders
Q2 202521,675$363.3K<0.1%00.0%UnchangedHolders
Q1 202521,675$333.1K<0.1%−40,000−64.9%ReducedHolders
Q4 202461,675$1.36M<0.1%+41,175+200.9%AddedHolders
Q3 202420,500$369.4K<0.1%00.0%UnchangedHolders
Q2 202420,500$333.1K<0.1%00.0%UnchangedHolders
Q1 202420,500$289.3K<0.1%00.0%UnchangedHolders
Q4 202320,500$214.0K<0.1%00.0%UnchangedHolders
Q3 202320,500$209.1K<0.1%00.0%UnchangedHolders
Q2 202320,500$154.4K<0.1%00.0%UnchangedHolders
Q1 202320,500$181.4K<0.1%−517−2.5%ReducedHolders
Q4 202221,017$191.7K<0.1%+357+1.7%AddedHolders
Q3 202220,660$166.0K<0.1%−247−1.2%ReducedHolders
Q2 202220,907$157.0K<0.1%+10.0%AddedHolders
Q1 202220,906$196.0K<0.1%−238,862−92.0%ReducedHolders
Q4 2021259,768$2.08M<0.1%+20.0%AddedHolders
Q3 2021259,766$2.53M<0.1%+9,972+4.0%AddedHolders
Q2 2021249,794$2.47M<0.1%−5,753−2.3%ReducedHolders
Q1 2021255,547$2.95M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.